Amphastar Pharmaceuticals, Inc. (AMPH)

NASDAQ: AMPH · Real-Time Price · USD

20.03

-0.50 (-2.44%)

At close: Jun 12, 2026, 4:00 PM EDT

20.09

+0.06 (0.30%)

After-hours: Jun 12, 2026, 4:10 PM EDT

Amphastar Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	720.53	719.89	731.97	644.4	498.99	437.77
Revenue Growth (YoY)	-1.39%	-1.65%	13.59%	29.14%	13.98%	25.13%
Cost of Revenue	379.4	363.83	358.11	293.27	250.13	238.03
Gross Profit	341.13	356.06	373.86	351.12	248.86	199.74
Selling, General & Admin	131.9	129.81	94.52	80.39	66.59	68.92
Research & Development	92.49	85.84	73.91	73.74	74.77	60.93
Total Operating Expenses	224.39	215.65	168.44	154.13	141.36	129.85
Operating Income	116.74	140.4	205.42	196.99	107.5	69.89
Interest Income	8.99	8.68	10.61	5.46	1.32	0.6
Interest Expense	-25.75	-25.48	-30.34	-27.16	-1.85	-0.89
Other Non-Operating Income (Expense)	2.83	0.02	4.08	-3.93	9.07	14.54
Total Non-Operating Income (Expense)	-13.93	-16.78	-15.66	-25.63	8.54	14.25
Pretax Income	102.81	123.62	189.76	171.36	116.04	84.14
Provision for Income Taxes	23.59	25.53	29.67	31.83	23.48	20.63
Net Income	72.81	98.09	160.09	139.53	92.56	63.51
Minority Interest in Earnings	-	-	0.57	1.98	1.18	-0.98
Net Income to Common	72.81	98.09	159.52	137.55	91.39	64.49
Net Income Growth	-37.42%	-38.51%	15.98%	50.51%	41.71%	8052.46%
Shares Outstanding (Basic)	46	47	48	48	49	48
Shares Outstanding (Diluted)	47	48	52	53	52	50
Shares Change (YoY)	-7.65%	-7.38%	-1.78%	1.09%	5.31%	1.34%
EPS (Basic)	1.71	2.10	3.29	2.85	1.88	1.30
EPS (Diluted)	1.66	2.03	3.06	2.60	1.74	1.25
EPS Growth	-39.86%	-33.66%	17.69%	49.43%	39.20%	4066.67%
Free Cash Flow	135.19	121.23	172.35	145.34	65.15	70.54
Free Cash Flow Growth	11.51%	-29.66%	18.58%	123.09%	-7.64%	201.30%
Free Cash Flow Per Share	2.85	2.51	3.31	2.74	1.24	1.42
Gross Margin	47.34%	49.46%	51.08%	54.49%	49.87%	45.63%
Operating Margin	16.20%	19.50%	28.06%	30.57%	21.54%	15.96%
Profit Margin	10.10%	13.63%	21.87%	21.65%	18.55%	14.51%
FCF Margin	18.76%	16.84%	23.55%	22.55%	13.06%	16.11%
EBITDA	174.17	197.1	258.39	235.02	132.27	93.15
EBITDA Margin	24.17%	27.38%	35.30%	36.47%	26.51%	21.28%
EBIT	116.74	140.4	205.42	196.99	107.5	69.89
EBIT Margin	16.20%	19.50%	28.06%	30.57%	21.54%	15.96%
Effective Tax Rate	22.94%	20.65%	15.64%	18.58%	20.23%	24.52%

SEC Filings: 10-K · 10-Q